相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
Jinyan Du et al.
NATURE BIOTECHNOLOGY (2009)
EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors
Li Li et al.
NEURO-ONCOLOGY (2009)
EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma
Qi-Wen Fan et al.
SCIENCE SIGNALING (2009)
Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization
Judith Schmiedel et al.
CANCER CELL (2008)
S6K1 plays a key role in glial transformation
Jean L. Nakamura et al.
CANCER RESEARCH (2008)
Identification of p18INK4c as a tumor suppressor gene in glioblastoma multiforme
David A. Solomon et al.
CANCER RESEARCH (2008)
Pten haploinsufficiency accelerates formation of high-grade astrocytomas
Chang-Hyuk Kwon et al.
CANCER RESEARCH (2008)
p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts
Eduard B. Dinca et al.
CANCER RESEARCH (2008)
DNA repair and cancer stem-like cells - Potential partners in glioma drug resistance?
Tor-Christian Aase Johannessen et al.
CANCER TREATMENT REVIEWS (2008)
Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors
Arkaitz Carracedo et al.
CELL CYCLE (2008)
Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2
Tobias Martens et al.
CLINICAL CANCER RESEARCH (2008)
Epidermal growth factor receptor inhibitors in neuro-oncology: Hopes and disappointments
Alba A. Brandes et al.
CLINICAL CANCER RESEARCH (2008)
Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples
Koji Yoshimoto et al.
CLINICAL CANCER RESEARCH (2008)
PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo
Dolores Hambardzumyan et al.
GENES & DEVELOPMENT (2008)
Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients:: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer
Fabio Efficace et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer
John V. Heymach et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase II study of imatinib in patients with recurrent gliomas of various histologies: A European organisation for research and treatment of cancer brain tumor group study
Eric Raymond et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor
Thomas E. Reznik et al.
MOLECULAR CANCER RESEARCH (2008)
Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity
Farnaz Yamoutpour et al.
MOLECULAR CANCER THERAPEUTICS (2008)
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Hongwu Zheng et al.
NATURE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
VEGF Trap induces antiglioma effect at different stages of disease
Candelaria Gomez-Manzano et al.
NEURO-ONCOLOGY (2008)
被撤回的出版物: The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility (Retracted article. See vol. 109, pg. 5548, 2012)
Jeroen J. Larnmerts van Bueren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4
Kunio Matsumoto et al.
PROTEOMICS (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
Tim F. Cloughesy et al.
PLOS MEDICINE (2008)
C-met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations
Steven F. Bellon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Preclinical efficacy of the c-met inhibitor CE-355621 in a U87 MG mouse xenograft model evaluated by F-18-FDG small-animal PET
Jeffrey R. Tseng et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
AMG 102, a fully human anti-hepatocyte growth factor/scatter factor neutralizing antibody, enhances the efficacy of temozolomide or docetaxel in U-87 MG cells and xenografts
H. Toni Jun et al.
CLINICAL CANCER RESEARCH (2007)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J. Vredenburgh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Jayne M. Stommel et al.
SCIENCE (2007)
Making a tumour's bed: glioblastoma stem cells and the vascular niche
Richard J. Gilbertson et al.
NATURE REVIEWS CANCER (2007)
IMC-A12, a human IgG, monoclonal antibody to the insulin-like growth factor I receptor
Eric K. Rowinsky et al.
CLINICAL CANCER RESEARCH (2007)
A dual phosphoinositide-3-kinase α/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma
Qi-Wen Fan et al.
CANCER RESEARCH (2007)
Trastuzumab-related cardiotoxicity: Calling into question the concept of reversibility
Melinda L. Telli et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma
Paul H. Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17
Paul E. Goss et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
An orally available small-molecule inhibitor of c-met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms
Helen Y. Zou et al.
CANCER RESEARCH (2007)
The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization
Terrance G. Johns et al.
CLINICAL CANCER RESEARCH (2007)
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
Jann N. Sarkaria et al.
MOLECULAR CANCER THERAPEUTICS (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma
Yi Yu et al.
CANCER RESEARCH (2007)
Sensitization of a glioblastoma multiforme (GBM) cell line by MP470: A novel c-met antagonist
J. Welsh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Panitumumab the first fully human monoclonal antibody: from the bench to the clinic
Michael Cohenuram et al.
ANTI-CANCER DRUGS (2007)
The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma
Klaus Podar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain
Jeffrey C. Lee et al.
PLOS MEDICINE (2006)
Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling
Tai W. Wong et al.
CLINICAL CANCER RESEARCH (2006)
A novel one-armed anti-c-met antibody inhibits glioblastoma growth in vivo
Tobias Martens et al.
CLINICAL CANCER RESEARCH (2006)
Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-Deficient and PTEN-intact glioblastoma cells
Maria Y. Wang et al.
CANCER RESEARCH (2006)
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08
Patrick Y. Wen et al.
CLINICAL CANCER RESEARCH (2006)
High-grade glioma formation results from postnatal Pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model
Qingxia Wei et al.
CANCER RESEARCH (2006)
Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas
L. Doherty et al.
NEUROLOGY (2006)
AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling
Markus J. Riemenschneider et al.
CANCER RESEARCH (2006)
Improving the delivery of therapeutic agents to CNS neoplasms: a clinical review
MA Badruddoja et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma
U Tabori et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity
A Petrelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo
S Uchinokura et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts
KJ Kim et al.
CLINICAL CANCER RESEARCH (2006)
Hypoxia inducible factor 1-alpha regulates of platelet derived growth factor-B in human glioblastoma cells
D Yoshida et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastorna multiforme
DA Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pathological and molecular progression of astrocytomas in a GFAP:: 12V=Ha-Ras mouse astrocytoma model
P Shannon et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
SM Chang et al.
INVESTIGATIONAL NEW DRUGS (2005)
Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma
Y Zhu et al.
CANCER CELL (2005)
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
DA Haas-Kogan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Expression of VEGF and its receptors in different brain tumors
HG Huang et al.
NEUROLOGICAL RESEARCH (2005)
AZD2171:: A highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.
SR Wedge et al.
CANCER RESEARCH (2005)
Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871
BD Cohen et al.
CLINICAL CANCER RESEARCH (2005)
The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants
S Berthou et al.
ONCOGENE (2004)
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor
P Michieli et al.
CANCER CELL (2004)
The Sema domain of Met is necessary for receptor dimerization and activation
M Kong-Beltran et al.
CANCER CELL (2004)
Phase II trial of gefitinib in recurrent glioblastoma
JN Rich et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma
O Arrieta et al.
CANCER (2002)
Epidermal growth factor receptor and Ink4a/Arf:: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis
RM Bachoo et al.
CANCER CELL (2002)
Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation
A Xiao et al.
CANCER CELL (2002)
Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells
T Glaser et al.
ONCOGENE (2001)
Gliomagenesis: Genetic alterations and mouse models
EC Holland
NATURE REVIEWS GENETICS (2001)
Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system
A Cerletti et al.
JOURNAL OF DRUG TARGETING (2000)
分享论文
